medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2015, Number 06

<< Back Next >>

Ginecol Obstet Mex 2015; 83 (06)

Interactions between markers of endothelial damage (homocysteine and asymmetric dimethylarginine) and antioxidants and B-vitamins in preeclamptic women

López-Alarcón M, Vital-Reyes VS, Montalvo-Velarde I, Hinojosa-Cruz JC, PuelloTE

Language: Spanish
References: 24
Page: 329-339
PDF size: 425.44 Kb.


ABSTRACT

Background: Preeclampsia is a pregnancy-related pathological condition triggered by an abnormal placentation which produces endothelial dysfunction (ED). ED, in turn, is associated with an increase in homocysteine (hcy) and asymmetric dimethylarginine (ADMA); these molecules are also increased when some of the B-vitamins are deficient. It is unclear whether increases in hcy and ADMA during preeclampsia are the result of ED, or the consequence of a B-vitamin deficiency.
Objective: To evaluate hcy, ADMA, folic acid (FA), vitamin B6 and B12 concentrations in patients with preeclampsia.
Methods: In a cross-sectional design 19 patients with severe preeclampsia (preeclampsia) and 57 with normal pregnancy (no-preeclampsia), paired by gestational age and body mass index, were studied. Plasma hcy, ADMA, FA and vitamins B6 and B12 were determined. Non-parametric statistics was used for between-groups comparisons and regression analyses to evaluate interactions among molecules.
Results: 72% of women were vitamin B6 deficient, 40% were deficient of B12 and 4% of FA. Preeclamptic patients presented hcy and ADMA concentrations higher than no-preeclamptic ones. Inferential analyses demonstrated that: hcy and ADMA are increased during preeclampsia independently from vitamins blood concentration; that the risk for preeclampsia is associated with high hcy but not with vitamins deficiency; and that the ratio L-arginine:ADMA decreases the preeclampsia risk.
Conclusion: In patients with preeclampsia, increases of hcy and ADMA are associated with ED, but not with deficiency of the vitamins involved in their metabolism.


REFERENCES

  1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631-44.

  2. Estadísticas IMSS. Sistema de información de mortalidad 2006 (SISMOR). Comités de mortalidad materna. Datamart de estadísticas médicas. www.imss.gob.mx

  3. Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol 2002; 57:609-613.

  4. Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 2007;109:168-80

  5. Martínez AO, Sánchez de Medina F. Arginina, óxido nítrico y función endotelial. Arch Pharm 2004; 45:303-317.

  6. Böger RH. Asymmetric dimethylarginine (ADMA) modulates endothelial function – therapeutic implications. Vasc Med 2003; 8:149-151.

  7. Siroen MPC, Teerlink T, Nijveldt RJ, Prins HA, Richir MC. The clinical significance of asymmetric dimethilarginine. Annu Nutr Rev, 2006; 26:203-228.

  8. Noorbakhsh M, Kianpour M, Nematbakhsh M. Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients. ISRN Obstet Gynecol 2013; 2013:104213.

  9. Tran CTL, Leiper JM, Vallance P. The DDAH/ADMA/NOS pathway. Atheroscler Suppl, 2003; 4:33-40.

  10. Anderssohn M, Maass LM, Diemert A, Luneburg N, Atzler D, Hecher K, Boger RH: Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in preeclampsia. Eur J Gynecol Reprod Biol 2012;161:152- 156.

  11. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-1057.

  12. Herrmann W, Isber S, Obeid R, Herrmann M, Jouma M. Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status. Clin Chem Lab Med 2005;43:1139–46

  13. de la Calle M, Usandizaga R, Sancha M, Magdaleno F, Cabrillo E. Homocisteína, ácido fólico y vitaminas del grupo B en Ginecología y Obstetricia. Act Obstet Ginecol 2001;13:237-248

  14. Böger RH, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci, 2001; 100:161-167.

  15. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol, 1999; 180: 660-664.

  16. Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol, 1998; 178:551-556.

  17. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently developed pre-eclampsia. Lancet, 2003; 361:1511-1517.

  18. Laskowska M, Laskowska K, Terbosh M, Oleszczuk JA. A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies. Med Sd Monit 2013;19:430-437.

  19. O’Broin SD, Kelleger B. Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol 1992;45:344-7.

  20. Dietary Reference Intake for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Institute of Medicine, Food and Nutrition Board. National Academy Press 1998 (USA).

  21. Gibson RS. Principles of Nutritional Assessment. Oxford University Press 2005. (USA).

  22. Powers R, Weissgerber TL, McGonigal S, Myerski A, Gallaher M, Speer PD, Roberts JM, Jeyabalan A, Hubel. [7-OR]: L-Citrulline administration increases the arginine/ADMA ratio, decreases blood pressure and improves vascular function in obese pregnant women. Pregnancy Hypertens 2015;5:4. doi: 10.1016/j.preghy.2014.10.011.

  23. Wen SW, Chen XK, Rodger M, White RR, Yang Q, Smith GN, Sigal RJ, Perkins SL, Walker MC. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 2008;198:45.e1-7

  24. Zhiwen L, Rongwei Y, Le Z, Hongtian L, Jianmeng L, Aiguo R: Folic acid supplementation during early pregnancy and the risk of gestational hypertension and preeclampsia. Hypertension 2013;61:873-879.3




2020     |     www.medigraphic.com